Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine

NCT02828020 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1672

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine, With or Without Aura

Interventions

DRUG: Ubrogepant
DRUG: Placebo-matching Ubrogepant

Sponsor

Allergan